Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8404976rdf:typepubmed:Citationlld:pubmed
pubmed-article:8404976lifeskim:mentionsumls-concept:C0023903lld:lifeskim
pubmed-article:8404976lifeskim:mentionsumls-concept:C0015625lld:lifeskim
pubmed-article:8404976lifeskim:mentionsumls-concept:C0279493lld:lifeskim
pubmed-article:8404976pubmed:issue8lld:pubmed
pubmed-article:8404976pubmed:dateCreated1993-10-26lld:pubmed
pubmed-article:8404976pubmed:abstractTextThe occurrence of liver tumours in the course of Fanconi anaemia (FA) has been well documented. We present a case, review the literature and conclude that androgen therapy would increase the risk of developing tumours, most of which appear to be benign (adenomas or peliosis) and androgen-dependent, generally decreasing in size after cessation of treatment. Survival of patients is poor, mostly because of the rapid evolution of the tumour. In the absence of an allogenic bone marrow transplantation, administration of haematopoietic growth factors might be effective. As a preventive measure, other types of unsubstituted androgens may be used.lld:pubmed
pubmed-article:8404976pubmed:languageenglld:pubmed
pubmed-article:8404976pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8404976pubmed:citationSubsetIMlld:pubmed
pubmed-article:8404976pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8404976pubmed:statusMEDLINElld:pubmed
pubmed-article:8404976pubmed:monthAuglld:pubmed
pubmed-article:8404976pubmed:issn0340-6199lld:pubmed
pubmed-article:8404976pubmed:authorpubmed-author:PhilippeNNlld:pubmed
pubmed-article:8404976pubmed:authorpubmed-author:GillyJJlld:pubmed
pubmed-article:8404976pubmed:authorpubmed-author:BertrandYYlld:pubmed
pubmed-article:8404976pubmed:authorpubmed-author:TouraineR LRLlld:pubmed
pubmed-article:8404976pubmed:authorpubmed-author:ForayPPlld:pubmed
pubmed-article:8404976pubmed:issnTypePrintlld:pubmed
pubmed-article:8404976pubmed:volume152lld:pubmed
pubmed-article:8404976pubmed:ownerNLMlld:pubmed
pubmed-article:8404976pubmed:authorsCompleteYlld:pubmed
pubmed-article:8404976pubmed:pagination691-3lld:pubmed
pubmed-article:8404976pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:8404976pubmed:meshHeadingpubmed-meshheading:8404976-...lld:pubmed
pubmed-article:8404976pubmed:meshHeadingpubmed-meshheading:8404976-...lld:pubmed
pubmed-article:8404976pubmed:meshHeadingpubmed-meshheading:8404976-...lld:pubmed
pubmed-article:8404976pubmed:meshHeadingpubmed-meshheading:8404976-...lld:pubmed
pubmed-article:8404976pubmed:meshHeadingpubmed-meshheading:8404976-...lld:pubmed
pubmed-article:8404976pubmed:meshHeadingpubmed-meshheading:8404976-...lld:pubmed
pubmed-article:8404976pubmed:meshHeadingpubmed-meshheading:8404976-...lld:pubmed
pubmed-article:8404976pubmed:year1993lld:pubmed
pubmed-article:8404976pubmed:articleTitleHepatic tumours during androgen therapy in Fanconi anaemia.lld:pubmed
pubmed-article:8404976pubmed:affiliationDepartment of Radiology, Hôpital Debrousse, Lyon, France.lld:pubmed
pubmed-article:8404976pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8404976pubmed:publicationTypeCase Reportslld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8404976lld:pubmed